Spotlight on GOT2 in Cancer Metabolism

References

• DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200. doi:10.1126/sciadv.1600200
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.006
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.1160809
   PubMed Web of Science ®Google Scholar
• Kerk SA, Papagiannakopoulos T, Shah YM, Lyssiotis CA. Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment. Nat Rev Cancer. 2021;21(8):510–525. doi:10.1038/s41568-021-00375-9
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10(9):671–684. doi:10.1038/nrd3504
   PubMed Web of Science ®Google Scholar
• Borst P. The malate-aspartate shuttle (Borst cycle): how it started and developed into a major metabolic pathway. IUBMB Life. 2020;72(11):2241–2259. doi:10.1002/iub.2367
   PubMed Web of Science ®Google Scholar
• Birsoy K, Wang T, Chen WW, Freinkman E, Abu-Remaileh M, Sabatini DM. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell. 2015;162(3):540–551. doi:10.1016/j.cell.2015.07.016
   PubMed Web of Science ®Google Scholar
• Garcia-Bermudez J, Baudrier L, La K, et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat Cell Biol. 2018;20(7):775–781. doi:10.1038/s41556-018-0118-z
   PubMed Web of Science ®Google Scholar
• Sullivan LB, Gui DY, Hosios AM, Bush LN, Freinkman E, Vander Heiden MG. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell. 2015;162(3):552–563. doi:10.1016/j.cell.2015.07.017
   PubMed Web of Science ®Google Scholar
• Sullivan LB, Luengo A, Danai LV, et al. Aspartate is an endogenous metabolic limitation for tumour growth. Nat Cell Biol. 2018;20(7):782–788. doi:10.1038/s41556-018-0125-0
   PubMed Web of Science ®Google Scholar
• Garcia-Bermudez J, Badgley MA, Prasad S, et al. Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia. Nat Metab. 2022;4(6):724–738. doi:10.1038/s42255-022-00583-z
   PubMedGoogle Scholar
• Chen -C-C, Li B, Millman SE, et al. Vitamin B6 addiction in acute myeloid leukemia. Cancer Cell. 2020;37(1):71–84.e77. doi:10.1016/j.ccell.2019.12.002
   PubMed Web of Science ®Google Scholar
• He Y, Deng F, Zhao S, et al. Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1. Epigenomics. 2019;11(9):1021–1036. doi:10.2217/epi-2019-0072
   PubMed Web of Science ®Google Scholar
• Hong R, Zhang W, Xia X, et al. Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation. Mol Oncol. 2019;13(4):959–977. doi:10.1002/1878-0261.12466
   PubMed Web of Science ®Google Scholar
• Meléndez-Rodríguez F, Urrutia AA, Lorendeau D, et al. HIF1α suppresses tumor cell proliferation through inhibition of aspartate biosynthesis. Cell Rep. 2019;26(9):2257–2265.e2254. doi:10.1016/j.celrep.2019.01.106
   PubMed Web of Science ®Google Scholar
• Ferreira WAS, de Oliveira EHC. Expression of GOT2 is epigenetically regulated by DNA methylation and correlates with immune infiltrates in clear-cell renal cell carcinoma. Curr Issues Mol Biol. 2022;44(6):2472–2489. doi:10.3390/cimb44060169
   PubMed Web of Science ®Google Scholar
• Stegen S, Rinaldi G, Loopmans S, et al. Glutamine metabolism controls chondrocyte identity and function. Dev Cell. 2020;53(5):530–544.e538. doi:10.1016/j.devcel.2020.05.001
   PubMed Web of Science ®Google Scholar
• Qi L, Martin-Sandoval MS, Merchant S, et al. Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration. Cell Stem Cell. 2021;28(11):1982–1999.e1988. doi:10.1016/j.stem.2021.07.011
   PubMed Web of Science ®Google Scholar
• van Karnebeek CDM, Ramos RJ, Wen XY, et al. Bi-allelic GOT2 mutations cause a treatable malate-aspartate shuttle-related encephalopathy. Am J Hum Genet. 2019;105(3):534–548. doi:10.1016/j.ajhg.2019.07.015
   PubMed Web of Science ®Google Scholar
• Kerk SA, Lin L, Myers AL, et al. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Elife. 2022;11:e73245.
   PubMed Web of Science ®Google Scholar
• Missailidis D, Sanislav O, Allan CY, Smith PK, Annesley SJ, Fisher PR. Dysregulated provision of oxidisable substrates to the mitochondria in ME/CFS lymphoblasts. Int J Mol Sci. 2021;22(4):2046. doi:10.3390/ijms22042046
   PubMed Web of Science ®Google Scholar
• Wesseling H, Chan MK, Tsang TM, et al. A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology. Neuropsychopharmacology. 2013;38(12):2532–2544. doi:10.1038/npp.2013.160
   PubMed Web of Science ®Google Scholar
• Gao Y, Mu J, Xu T, et al. Metabolomic analysis of the hippocampus in a rat model of chronic mild unpredictable stress-induced depression based on a pathway crosstalk and network module approach. J Pharm Biomed Anal. 2021;193:113755. doi:10.1016/j.jpba.2020.113755
   PubMed Web of Science ®Google Scholar
• Honorat JA, Nakatsuji Y, Shimizu M, et al. Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner. PLoS One. 2017;12(11):e0187215. doi:10.1371/journal.pone.0187215
   PubMed Web of Science ®Google Scholar
• Bölsterli BK, Boltshauser E, Palmieri L, et al. Ketogenic diet treatment of defects in the mitochondrial malate aspartate shuttle and pyruvate carrier. Nutrients. 2022;14(17):3605. doi:10.3390/nu14173605
   PubMed Web of Science ®Google Scholar
• Li K, Zheng Y, Wang X. The potential relationship between HIF-1α and amino acid metabolism after hypoxic ischemia and dual effects on neurons. Front Neurosci. 2021;15:676553. doi:10.3389/fnins.2021.676553
   PubMed Web of Science ®Google Scholar
• Son J, Lyssiotis CA, Ying H, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496(7443):101–105. doi:10.1038/nature12040
   PubMed Web of Science ®Google Scholar
• Chakrabarti G, Moore ZR, Luo X, et al. Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone. Cancer Metab. 2015;3(1):12. doi:10.1186/s40170-015-0137-1
   PubMedGoogle Scholar
• Yang S, Hwang S, Kim M, Seo SB, Lee JH, Jeong SM. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition. Cell Death Dis. 2018;9(2):55. doi:10.1038/s41419-017-0089-1
   PubMedGoogle Scholar
• Honma K, Kamikubo M, Mochizuki K, Goda T. Insulin-induced inhibition of gluconeogenesis genes, including glutamic pyruvic transaminase 2, is associated with reduced histone acetylation in a human liver cell line. Metabolism. 2017;71:118–124. doi:10.1016/j.metabol.2017.03.009
   PubMed Web of Science ®Google Scholar
• Li Y, Li B, Xu Y, et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors. Cancer Res. 2022;82(18):3223–3235. doi:10.1158/0008-5472.CAN-22-0042
   PubMed Web of Science ®Google Scholar
• Arnold PK, Finley LWS. Regulation and function of the mammalian tricarboxylic acid cycle. J Biol Chem. 2023;299(2):102838. doi:10.1016/j.jbc.2022.102838
   PubMed Web of Science ®Google Scholar
• Feist M, Schwarzfischer P, Heinrich P, et al. Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression. Nat Commun. 2018;9(1):1514. doi:10.1038/s41467-018-03803-x
   PubMedGoogle Scholar
• Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo AP. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101416. doi:10.1016/j.beem.2020.101416
   PubMed Web of Science ®Google Scholar
• Remacha L, Comino-Méndez I, Richter S, et al. Targeted exome sequencing of Krebs cycle genes reveals candidate cancer-predisposing mutations in pheochromocytomas and paragangliomas. Clin Cancer Res. 2017;23(20):6315–6324. doi:10.1158/1078-0432.CCR-16-2250
   PubMed Web of Science ®Google Scholar
• Dwight T, Kim E, Novos T, Clifton-Bligh RJ. Metabolomics in the diagnosis of pheochromocytoma and paraganglioma. Horm Metab Res. 2019;51(7):443–450. doi:10.1055/a-0926-3790
   PubMed Web of Science ®Google Scholar
• Heather LC, Cole MA, Lygate CA, et al. Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovasc Res. 2006;72(3):430–437. doi:10.1016/j.cardiores.2006.08.020
   PubMed Web of Science ®Google Scholar
• Kalinowska A, Górski J, Harasim E, Harasiuk D, Bonen A, Chabowski A. Differential effects of chronic, in vivo, PPAR’s stimulation on the myocardial subcellular redistribution of FAT/CD36 and FABPpm. FEBS Lett. 2009;583(15):2527–2534. doi:10.1016/j.febslet.2009.07.008
   PubMed Web of Science ®Google Scholar
• Nie J, Ngokana LD, Kou J, et al. Low-dose ethanol intake prevents high-fat diet-induced adverse cardiovascular events in mice. Food Funct. 2020;11(4):3549–3562. doi:10.1039/C9FO02645B
   PubMed Web of Science ®Google Scholar
• Han -X-X, Chabowski A, Tandon NN. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am J Physiol Endocrinol Metab. 2007;293(2):E566–E575. doi:10.1152/ajpendo.00106.2007
   PubMed Web of Science ®Google Scholar
• Chabowski A, Momken I, Coort SL, et al. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol Cell Biochem. 2006;288(1–2):201–212. doi:10.1007/s11010-006-9140-8
   PubMed Web of Science ®Google Scholar
• Holloway GP, Lally J, Nickerson JG, et al. Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle. J Physiol. 2007;582(1):393–405. doi:10.1113/jphysiol.2007.135301
   PubMed Web of Science ®Google Scholar
• Jeppesen J, Albers P, Luiken JJ, Glatz JF, Kiens B. Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma. Mol Cell Biochem. 2009;326(1–2):45–53. doi:10.1007/s11010-008-0006-0
   PubMed Web of Science ®Google Scholar
• Nickerson JG, Alkhateeb H, Benton CR, et al. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J Biol Chem. 2009;284(24):16522–16530. doi:10.1074/jbc.M109.004788
   PubMed Web of Science ®Google Scholar
• Sookoian S, Castaño GO, Scian R, et al. Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. Am J Clin Nutr. 2016;103(2):422–434. doi:10.3945/ajcn.115.118695
   PubMed Web of Science ®Google Scholar
• Challa TD, Straub LG, Balaz M, et al. Regulation of de novo adipocyte differentiation through cross talk between adipocytes and preadipocytes. Diabetes. 2015;64(12):4075–4087. doi:10.2337/db14-1932
   PubMed Web of Science ®Google Scholar
• Abrego J, Sanford-Crane H, Oon C, et al. A cancer cell-intrinsic GOT2-PPARd axis suppresses antitumor immunity. Cancer Discov. 2022;12(10):2414–2433. doi:10.1158/2159-8290.CD-22-0661
   PubMed Web of Science ®Google Scholar
• Du F, Chen J, Liu H, et al. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis. Cell Death Dis. 2019;10(3):239. doi:10.1038/s41419-019-1481-9
   PubMedGoogle Scholar
• Zhu Y, Li T, Ramos da Silva S, et al. A critical role of glutamine and asparagine γ-nitrogen in nucleotide biosynthesis in cancer cells hijacked by an oncogenic virus. mBio. 2017;8(4). doi:10.1128/mBio.01179-17
   Web of Science ®Google Scholar
• Missiaen R, Anderson NM, Kim LC, et al. GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. Cell Metab. 2022;34(8):1151–1167.e1157. doi:10.1016/j.cmet.2022.06.010
   PubMed Web of Science ®Google Scholar
• Jiang H, Stabler SP, Allen RH, Abman SH, Maclean KN. Altered hepatic sulfur metabolism in cystathionine β-synthase-deficient homocystinuria: regulatory role of taurine on competing cysteine oxidation pathways. FASEB J. 2014;28(9):4044–4054. doi:10.1096/fj.14-253633
   PubMed Web of Science ®Google Scholar
• Liang Y, Liu D, Ochs T, et al. Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats. Lab Invest. 2011;91(1):12–23. doi:10.1038/labinvest.2010.156
   PubMed Web of Science ®Google Scholar
• Lyssiotis CA, Kimmelman AC. Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 2017;27(11):863–875. doi:10.1016/j.tcb.2017.06.003
   PubMed Web of Science ®Google Scholar
• Li F, Simon MC. Cancer cells don’t live alone: metabolic communication within tumor microenvironments. Dev Cell. 2020;54(2):183–195. doi:10.1016/j.devcel.2020.06.018
   PubMed Web of Science ®Google Scholar
• Schwörer S, Vardhana SA, Thompson CB. Cancer metabolism drives a stromal regenerative response. Cell Metab. 2019;29(3):576–591. doi:10.1016/j.cmet.2019.01.015
   PubMed Web of Science ®Google Scholar
• Steele NG, Carpenter ES, Kemp SB, et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nature Cancer. 2020;1(11):1097–1112.
   PubMedGoogle Scholar
• Hickman TL, Choi E, Whiteman KR, et al. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity. PLoS One. 2022;17(5):e0266980. doi:10.1371/journal.pone.0266980
   PubMed Web of Science ®Google Scholar
• Jin M, Shi C, Hua Q, et al. High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis. Aging. 2020;12(11):10381–10397. doi:10.18632/aging.103264
   PubMedGoogle Scholar
• Yang H, Zhou L, Shi Q, et al. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth. EMBO J. 2015;34(8):1110–1125. doi:10.15252/embj.201591041
   PubMed Web of Science ®Google Scholar
• Wang T, Yao W, Li J, He Q, Shao Y, Huang F. Acetyl-CoA from inflammation-induced fatty acids oxidation promotes hepatic malate-aspartate shuttle activity and glycolysis. Am J Physiol Endocrinol Metab. 2018;315(4):E496–E510. doi:10.1152/ajpendo.00061.2018
   PubMed Web of Science ®Google Scholar
• Biancur DE, Paulo JA, Małachowska B, et al. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun. 2017;8(1):15965. doi:10.1038/ncomms15965
   PubMedGoogle Scholar
• Altea-Manzano P, Vandekeere A, Edwards-Hicks J, et al. Reversal of mitochondrial malate dehydrogenase 2 enables anaplerosis via redox rescue in respiration-deficient cells. Mol Cell. 2022;82(23):4537–4547.e7. doi:10.1016/j.molcel.2022.10.005
   PubMed Web of Science ®Google Scholar